Phase 2 Trial
Clinical Trials
A Phase 2 trial tests a drug in 100–300 patients with the target condition to evaluate efficacy, refine dosing, and gather more safety data. Strong Phase 2 results de-risk the program before the larger, more expensive Phase 3.
Related terms
Learn more
Track Phase 2 Trial across 1,000+ biotechs
BioSniper monitors FDA decisions, clinical trials, and catalysts in real time — with evidence-backed AI analysis.
Start Free